Immusoft Applies Computer Science Knowledge to Disease

Although the concept of cell programming isn't new, Immusoft Corp.'s approach represents a new spin on the science.

For a biotech company, Seattle-based Immusoft started with a decidedly different pedigree. With a background in computer sciences rather than chemistry or biology, Matthew Scholz, the company's founder and CEO, conceived an idea to fight disease by modifying information in human immune cells.